Relationship between temporal rhythm-based classification of atrial fibrillation and stroke: real-world vs. clinical trial Wern Yew DingJosé Miguel Rivera-CaravacaGregory Y. H. Lip OriginalPaper Open access 15 April 2022 Pages: 1 - 6
Nitric oxide acute kidney injury (NO-AKI) pilot trial Rony N. LahoudHarold L. DauermanRichard J. Solomon BriefCommunication 08 April 2022 Pages: 7 - 10
Contact system activation in disseminated intravascular coagulation: activities of prekallikrein and high-molecular-weight kininogen are significant risk factors Sooyong ParkJa-Yoon GuHyun Kyung Kim BriefCommunication 07 January 2022 Pages: 11 - 14
Circadian variations of platelet reactivity on clopidogrel in patients treated with elective percutaneous coronary intervention Michele Mattia ViscusiFabio MangiacapraFrancesco Grigioni BriefCommunication 21 April 2022 Pages: 15 - 19
Efficacy and safety of app-based remote warfarin management during COVID-19-related lockdown: a retrospective cohort study Shaojun JiangMeina LvJinhua Zhang OriginalPaper 29 January 2022 Pages: 20 - 28
“Lockdown-thrombosis”—an unexpected problem of the COVID-19 pandemic? Chaozer ErJing Yuan TanHeng Joo Ng Letter to the Editor 28 June 2022 Pages: 29 - 32
Effectiveness and safety of oral anticoagulants in non-valvular atrial fibrillation patients with prior bleeding events: a retrospective analysis of administrative claims databases Gregory Y. H. LipAllison KeshishianSteven Deitelzweig OriginalPaper Open access 17 May 2022 Pages: 33 - 46
Impact of thrombus burden on long-term clinical outcomes in patients with either anterior or non-anterior ST-segment elevation myocardial infarction Paola ScarparoMenno van GamerenRoberto Diletti OriginalPaper Open access 26 November 2021 Pages: 47 - 57
Prognostic impact of acute kidney injury in patients with acute pulmonary embolism data from the RIETE registry Martin MurgierLaurent BertolettiRIETE Investigators OriginalPaper 24 January 2022 Pages: 58 - 66
Direct oral anticoagulants versus warfarin in patients with single or double antibody-positive antiphospholipid syndrome Briana WilliamsJoseph J. SaseenSurabhi Palkimas OriginalPaper 24 November 2021 Pages: 67 - 73
Comparison of 4-factor PCC reversal of apixaban and rivaroxaban versus warfarin for intracranial hemorrhage Stacy PasciollaKevin WojcikLauren A. Igneri OriginalPaper 26 November 2021 Pages: 74 - 81
Single versus multiple and incidental versus symptomatic subsegmental pulmonary embolism: clinical characteristics and outcome Yumiko Hirao-TryDanielle T. VlaznyWaldemar E. Wysokinski OriginalPaper 07 January 2022 Pages: 82 - 90
Prevalence of recommended anticoagulation by guidelines preadmission and its impact on the incidence of acute myocardial infarction (AMI) and in-hospital outcomes after AMI in atrial fibrillation patients Ying BaiXin-Yao LiuPeng Zhong OriginalPaper 24 January 2022 Pages: 91 - 96
Tissue factor: a neglected role in cancer biology Haiyuan LiYang YuHao Chen ReviewPaper 28 June 2022 Pages: 97 - 108
Management of bone marrow biopsy related bleeding risks: a retrospective observational study Lucile GrangeMartin KillianEmilie Chalayer BriefCommunication 24 November 2021 Pages: 109 - 114
Incremental cost of venous thromboembolism in trauma patients with contraindications to prophylactic anticoagulation: a prospective economic study Kwok M. HoFrederick B. RogersSana Nasim OriginalPaper 06 January 2022 Pages: 115 - 122
Efficacy of interatrial shunt devices: an opening window to acute pulmonary hypertensive crisis and chronic pulmonary arterial hypertension Lifan YangLei ZhangJunbo Ge OriginalPaper 13 March 2022 Pages: 123 - 131
Global coagulation assays in hypercoagulable states Hui Yin LimGeoffrey DonnanPrahlad Ho ReviewPaper 08 January 2022 Pages: 132 - 144
Inpatient Management of Pulmonary Embolism: Clinical Characteristics and Mortality in a High-Volume Tertiary Care Center Harsha V. MudrakolaSean M. CaplesSumera R. Ahmad OriginalPaper 13 January 2022 Pages: 145 - 152
Dual antiplatelet therapy in the contemporary drug-eluting stents era: from vulnerable stents to vulnerable patients Stefano BenenatiItalo Porto Editorial 02 March 2022 Pages: 153 - 155
Recurrent hematuria and painful necrotic purpura induced by acquired Protein S deficiency associated with monoclonal immunoglobulin Wenjiao TangYong Guo OriginalPaper 15 January 2022 Pages: 156 - 161
Arterial and venous involvement in Behçet’s syndrome: a narrative review Neera Toledo-SamaniegoCrhistian Mario OblitasFrancisco Galeano-Valle ReviewPaper 19 February 2022 Pages: 162 - 171
Impact of poly-arginine peptides R18D and R18 on alteplase and tenecteplase thrombolysis in vitro, and neuroprotective stability to proteolysis Bruno P. MeloniDavid J. BlackerNeville W. Knuckey OriginalPaper Open access 19 March 2022 Pages: 172 - 182
The use of colchicine as an anti-inflammatory agent for stroke prevention in patients with coronary artery disease: a systematic review and meta-analysis Claire X. Y. GohYing Kiat TanBenjamin Y. Q. Tan OriginalPaper 10 May 2022 Pages: 183 - 190
Answer to “REPLY to Association between Plasmatic Oxidative Stress and Thrombosis in Primary Antiphospholipid Syndrome” Camila de O. VazBruna M. MazettoFernanda Andrade Orsi Letter to the Editor 13 April 2022 Pages: 191 - 192
Confirmation of the utility of the Wells’ Score for pulmonary embolism in patients with sickle cell disease Jori E. MaySteven D. LauzonJulie Kanter Letter to the Editor 19 April 2022 Pages: 193 - 196